NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
Jimmy J. Caudell(Moffitt Cancer Center), Susan Darlow(National Comprehensive Cancer Network), David A. Schwartz(St. Jude Children's Research Hospital), David G. Pfister(Memorial Sloan Kettering Cancer Center), Frank Worden(University of Michigan), Antonio Jimeno(University of Colorado Cancer Center), David J. Sher(DePaul University), Ellie Maghami(City Of Hope National Medical Center), Debra S. Leizman(Cleveland Clinic), James W. Rocco(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Maie A. St. John(University of Colorado Cancer Center), Jennifer L. Burns(National Comprehensive Cancer Network), P. Savvides, Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Ying J. Hitchcock(University of Utah), Justine Y. Bruce(University of Wisconsin Carbone Cancer Center), Sharon Spencer(University of Colorado Cancer Center), Loren K. Mell(University of California San Diego), Anthony J. Cmelak(Breast Cancer Research Foundation), David M. Brizel(Duke University), Andrew C. Birkeland(University of California, Davis), Randal S. Weber(The University of Texas MD Anderson Cancer Center), Paul M. Busse(Massachusetts General Hospital), Douglas R. Adkins(Washington University in St. Louis), A. Dimitrios Colevas(Cancer Institute (WIA)), Wesley L. Hicks, Maura L. Gillison(The University of Texas MD Anderson Cancer Center), J.L. Geiger(Cleveland Clinic), Robert I. Haddad(Georgetown University), Thomas J. Galloway(Fox Chase Cancer Center), Sue S. Yom(University of California, San Francisco), Cristina P. Rodriguez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Gregory S. Weinstein(University of Pennsylvania), Weining Zhen(Susan Thompson Buffett Foundation), Bharat B. Mittal(Northwestern University), Harlan A. Pinto(Cancer Institute (WIA)), David W. Eisele(Sidney Kimmel Comprehensive Cancer Center)
Cited by 532
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k